BIOMAT Database Logo BIOMAT Database Logo

Point mutations of the topoisomerase IIalpha gene in patients with small cell lung cancer treated with etoposide. 1996

A Kubo, and A Yoshikawa, and T Hirashima, and N Masuda, and M Takada, and J Takahara, and M Fukuoka, and K Nakagawa
Department of Internal Medicine, Osaka Prefectural Habikino Hospital, Japan.

Reverse transcription-PCR-single-strand conformation polymorphism analysis was performed to detect topoisomerase IIalpha mutations using total RNA from 19 bronchial biopsy specimens obtained from 13 patients with small cell lung cancer. An abnormally migrating single-strand conformation polymorphism band was observed in one tumor sample from a patient treated with etoposide-containing chemotherapy. DNA sequence analysis of this tumor showed two transversions at codons 486 (G to A) and 494 (A to G), resulting in two missense mutations (Arg to Lys and Glu to Gly, respectively). The codon 486 mutation was identical to that previously found in two cell lines selected for amsacrine resistance. These results demonstrate that mutations of topoisomerase IIalpha occur in patients with small cell lung cancer. The significance of these mutations in the development of resistance to etoposide needs further investigation.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D003062 Codon A set of three nucleotides in a protein coding sequence that specifies individual amino acids or a termination signal (CODON, TERMINATOR). Most codons are universal, but some organisms do not produce the transfer RNAs (RNA, TRANSFER) complementary to all codons. These codons are referred to as unassigned codons (CODONS, NONSENSE). Codon, Sense,Sense Codon,Codons,Codons, Sense,Sense Codons
D004250 DNA Topoisomerases, Type II DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex. DNA Topoisomerase (ATP-Hydrolysing),DNA Topoisomerase II,DNA Topoisomerase II alpha,DNA Topoisomerase II beta,DNA Type 2 Topoisomerase,TOP2A Protein,TOP2B Protein,Topoisomerase II,Topoisomerase II alpha,Topoisomerase II beta,Type II DNA Topoisomerase,alpha, Topoisomerase II,beta, Topoisomerase II
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005047 Etoposide A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle. Demethyl Epipodophyllotoxin Ethylidine Glucoside,Celltop,Eposide,Eposin,Eto-GRY,Etomedac,Etopos,Etoposide Pierre Fabre,Etoposide Teva,Etoposide, (5S)-Isomer,Etoposide, (5a alpha)-Isomer,Etoposide, (5a alpha,9 alpha)-Isomer,Etoposide, alpha-D-Glucopyranosyl Isomer,Etoposido Ferrer Farma,Exitop,Lastet,NSC-141540,Onkoposid,Riboposid,Toposar,VP 16-213,VP-16,Vepesid,Vépéside-Sandoz,Eto GRY,Etoposide, alpha D Glucopyranosyl Isomer,NSC 141540,NSC141540,Teva, Etoposide,VP 16,VP 16 213,VP 16213,VP16,Vépéside Sandoz,alpha-D-Glucopyranosyl Isomer Etoposide
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Kubo, and A Yoshikawa, and T Hirashima, and N Masuda, and M Takada, and J Takahara, and M Fukuoka, and K Nakagawa
Point mutations in the topoisomerase I gene in patients with non-small cell lung cancer treated with irinotecan.
March 2002, Lung cancer (Amsterdam, Netherlands),
A Kubo, and A Yoshikawa, and T Hirashima, and N Masuda, and M Takada, and J Takahara, and M Fukuoka, and K Nakagawa
Excision repair cross complementing-1 and topoisomerase IIalpha gene expression in small-cell lung cancer patients treated with platinum and etoposide: a retrospective study.
June 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,
A Kubo, and A Yoshikawa, and T Hirashima, and N Masuda, and M Takada, and J Takahara, and M Fukuoka, and K Nakagawa
Outcomes of small cell lung cancer patients treated with cisplatin-etoposide versus carboplatin-etoposide.
February 2015, American journal of clinical oncology,
A Kubo, and A Yoshikawa, and T Hirashima, and N Masuda, and M Takada, and J Takahara, and M Fukuoka, and K Nakagawa
Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.
August 1999, Clinical cancer research : an official journal of the American Association for Cancer Research,
A Kubo, and A Yoshikawa, and T Hirashima, and N Masuda, and M Takada, and J Takahara, and M Fukuoka, and K Nakagawa
Topoisomerase IIalpha and other drug resistance markers in advanced non-small cell lung cancer.
May 2001, Lung cancer (Amsterdam, Netherlands),
A Kubo, and A Yoshikawa, and T Hirashima, and N Masuda, and M Takada, and J Takahara, and M Fukuoka, and K Nakagawa
Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecan.
October 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
A Kubo, and A Yoshikawa, and T Hirashima, and N Masuda, and M Takada, and J Takahara, and M Fukuoka, and K Nakagawa
Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase IIalpha gene transfer is independent of topoisomerase IIbeta.
September 2001, British journal of cancer,
A Kubo, and A Yoshikawa, and T Hirashima, and N Masuda, and M Takada, and J Takahara, and M Fukuoka, and K Nakagawa
Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
April 2002, Cancer,
A Kubo, and A Yoshikawa, and T Hirashima, and N Masuda, and M Takada, and J Takahara, and M Fukuoka, and K Nakagawa
Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells.
September 1999, Cancer research,
A Kubo, and A Yoshikawa, and T Hirashima, and N Masuda, and M Takada, and J Takahara, and M Fukuoka, and K Nakagawa
[K-RAS gene mutations in patients with non-small cell lung cancer].
June 2010, Zhongguo fei ai za zhi = Chinese journal of lung cancer,
Copied contents to your clipboard!